Zynext Ventures

Zynext Ventures operates as a venture capital firm, strategically investing in disruptive, early-stage biotech and healthcare companies. The firm focuses on nascent technologies in areas such as gene and cell therapy, providing capital and guidance. This approach aims to accelerate the development of innovative medical solutions within the evolving healthcare landscape.

Founded by Mitesh Shah, Zynext Ventures emerged as the dedicated investment arm of Zydus Lifesciences. Its inception was driven by the strategic insight to proactively engage with and cultivate the future of healthcare through targeted early-stage investments. Mitesh Shah, as Founder and Principal, directs the firm's investment philosophy and strategic focus.

Innovative biotech and healthcare startups seeking crucial early-stage capital and strategic partnership are the core recipients of Zynext Ventures' support. The firm's vision centers on catalyzing the growth of companies developing transformative medical technologies. This commitment aims to significantly advance global healthcare, fostering the next generation of breakthroughs.